Flecainide
Cardiac anti-arrhythmic drug. Acts by blocking fast sodium channels. For monitoring purposes, blood should not be drawn until a steady state has been attained. Clinical indication: therapeutic drug monitoring of flecainide.
| Tube | 04 (EP) - EDTA Plasma |
|---|---|
| ID | Tests&Tubes0188 |
| Additional Information | Normal dose in adults is 200-400 mg/day. Excreted unchanged in urine. Half life is 14 hours, 20 hours if have ventricular arrhythmias. Steady state plasma levels achieved after 3-5 days of treatment. |
| Turn Around | Turnaround time stated by Cardiff: 7 days |
| Send to | Blood Sciences LGI (Test referred to: Cardiff toxicology lab) |
| Contact | For further details please contact Leeds Pathology customer services: leedsth-tr.pathologycustomerservice@nhs.net. |
| Advice | Full information on all referred tests can be found on the referred tests information database, EQMS reference BSF2REC17003. |
| Collection Con | Instructions to lab: Centrifuge, separate and freeze plasma. Minimum 1mL plasma. |
| Sample REQ | Blood |
| Ref. Range Notes | Therapeutic range 0.15 - 0.90 mg/L |
| Units | mg/L |
| Telepath | LFLEC / JFLEC |
| ICE Codes | LFLEC / JFLEC |
